Filter
Reset all

Subjects

Content Types

Countries

Data access

Data access restrictions

Database access

Data licenses

Data upload

Data upload restrictions

Enhanced publication

Institution responsibility type

Institution type

Keywords

PID systems

Provider types

Quality management

Repository languages

Software

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 3 result(s)

ARS

Antibiotika-Resistenz-Surveillance

Subject(s)
Content type(s)
Country
With ARS - Antimicrobial Resistance Surveillance in Germany - the infrastructure for a nationwide surveillance of antimicrobial resistance has been established, which covers both the inpatient medical care and the ambulatory care sector. This is intended to reliable data on the epidemiology of antimicrobial resistance in Germany and differential statements provided by structural features of the health care and by region are possible. ARS is designed as a laboratory-based surveillance system for continuous collection of resistance data from routine for the full range of clinically relevant bacterial pathogens. Project participants and thus data suppliers are laboratories that analyze samples of medical facilities and doctors' offices microbiologically.

Comprehensive Antibiotic Resistance Database

CARD

Subject(s)
Content type(s)
Country
A bioinformatic database of antimicrobial resistance genes, their products and associated phenotypes.

Shared Platform for Antibiotic Research and Knowledge

SPARK

Subject(s)
Content type(s)
Country
An interactive database hosted by Collaborative Drug Discovery for antibiotic susceptibility data (MIC and IC50). Data is extracted from journal articles and/or contributed by different organizations and individuals. In some cases, the data has not previously been published. Access to the database is open to everyone and can be requested at pewtrusts.org/spark-antibiotic-discovery. Effective November 18, 2021, Pew transferred all SPARK data to The University of Queensland’s Community for Open Antimicrobial Drug Discovery (CO-ADD). Please visit spark.co-add.org https://co-add.org/.